RecruitingNCT07163013
About this title
Digital Cognitive Behavioral Therapy for Chinese Adolescents With Depressive Symptoms(CADS-D )
Read the official source — NCT07163013Official study titleDigital Cognitive Behavioral Therapy for Chinese Adolescents With Depressive Symptoms(CADS-D ): A Randomized Clinical Trial
In ChongqingDepressionInterventional studyAges 12–18
- Countries
- China
- Sponsor
- First Affiliated Hospital of Chongqing Medical University
RecruitingNCT06786936
About this title
Evaluating the Role of IL-17 as an Orchestrator of Peripheral-central Cross Talk in Depressive Symptoms
Read the official source — NCT06786936Official study titleEvaluating the Role of IL-17 as an Orchestrator of Peripheral-central Cross Talk in Depressive Symptoms
In GlasgowDepressionObservational studyAges 18–74
- Countries
- United Kingdom
- Sponsor
- NHS Greater Glasgow and Clyde
RecruitingNCT07033741
About this title
Predictors and Process Moderators of EMDR Therapy for Depressive Symptoms
Read the official source — NCT07033741Official study titlePredictors and Process Moderators of EMDR Therapy for Depressive Symptoms: Protocol for a Real-world Prospective Observational Study
In TurinDepression, AnxietyObservational studyAges 18+
- Countries
- Italy
- Sponsor
- University of Turin, Italy
RecruitingNCT07007234
About this title
Sedentary Behavior and Depressive Symptoms
Read the official source — NCT07007234What is this study about?This study assesses depression symptoms.
Multiple locations, including São PauloDepression, AnxietyBehavioural studyAges 18+
- Countries
- Brazil
- Sponsor
- University of Sao Paulo General Hospital
RecruitingNCT06294184
About this title
TDCS Interventions for Subthreshold Depressive Symptoms in Young Individuals.
Read the official source — NCT06294184Official study titleTranscranial Direct Current Stimulation Interventions for Subthreshold Depressive Symptoms in Young Individuals.
In GuangzhouDepressionDevice studyAges 12–25
- Countries
- China
- Sponsor
- Guangzhou Psychiatric Hospital
Not Yet RecruitingNCT06382389
Official study titleEfficacy of EMONO as an add-on Therapy to Conventional Antidepressants for the Treatment of Depressive Symptoms in Nursing-home Residents With Neurocognitive Disorders: a Randomized Controlled Trial
This study isn't recruiting yet.
Location not clearly listedDepressionMedication studyAges 60+
- Countries
- Sponsor
- University Hospital, Tours
Not Yet RecruitingNCT07112118
Official study titleMultimodal Identification of Depressive Symptoms
This study isn't recruiting yet.
In WuhanDepressionObservational studyAges 60–100
- Countries
- China
- Sponsor
- Wuhan Mental Health Centre
Not Yet RecruitingNCT07415850
Official study titleThe Effect of a Four-Week Hatha Yoga Intervention to Improve Quality of Life, Anxiety, and Depressive Symptoms in Individuals Undergoing Assisted Reproductive Technology (ART) Treatment: A Randomized Controlled Trial
This study isn't recruiting yet.
In VillanovaDepression, AnxietyBehavioural studyAges 18+
- Countries
- United States
- Sponsor
- Villanova University
Not Yet RecruitingNCT06805266
Official study titleAn Open Study to Evaluate the Efficacy of Vortioxetine on Freezing of Gait in Patients Affected by Parkinson Disease with Depressive Symptoms
This study isn't recruiting yet.
Location not clearly listedDepressionMedication studyAges 18+
- Countries
- Sponsor
- Marianna Amboni
CompletedNCT07053345
Official study titleAn Interventional, Open-label, Single Arm, Multicenter Study to Evaluate the Efficacy and Safety of Esketamine Nasal Spray in Korean Participants With Treatment-Resistant Depression(TRD)
This study has finished and is no longer accepting participants.
Multiple locations, including Goyang Si Gyeonggi DoDepressionMedication studyAges 18–64
- Countries
- South Korea
- Sponsor
- Janssen Korea, Ltd., Korea
CompletedNCT04080752
What is this study about?This study evaluated the safety and effectiveness of JNJ-61393215 for people with depression.
This study has finished and is no longer accepting participants.
Multiple locations, including Garden GroveDepressionMedication studyAges 18–64
- Countries
- United States, United Kingdom, Moldova, + 2 others
- Sponsor
- Janssen Research & Development, LLC
CompletedNCT05593029
What is this study about?This study evaluated the safety and effectiveness of SEP-363856 for people with depression.
This study has finished and is no longer accepting participants.
Multiple locations, including BirminghamDepressionMedication studyAges 18–65
- Countries
- United States, Canada, Bulgaria, + 4 others
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc. (Pharmaceutical company)